FMR1 and fragile X syndrome: Clinical studies in FXS patients combining the high-resolution FMR1 expression level analysis with neurobehavioral assessments indicate that FMRP expression in the brain is the ultimate factor determining the severity of the neurobehavioral phenotype in humans with FXS, including autism spectrum disorders (ASDs) [7].